Search - tctmd.com

Displaying 741 - 760 of 881

Sort: Relevancy | Date

News Daily News

Novel Device Shows Promise for Safe, Effective LAA Closure

Yael L. Maxwell

October 12, 2012

Presentation

Percutaneous LAA Suture Ligation Using the LARIAT Device in Patients with A-fib

Presenter: K. Bartus

October 11, 2012

News Daily News

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

L.A. McKeown

October 10, 2012

Presentation

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Presenter: Greg C. Flaker

October 09, 2012

News Daily News

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

L.A. McKeown

October 09, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

Presentation

Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib

Presenter: Renato D. Lopes

October 03, 2012

News Daily News

JACC Viewpoint: Studies Needed on Long-term Consequences of ‘Silent’ Cerebral Infarcts

L.A. McKeown

October 03, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

Risk Score Predicts Stroke or Death in Carotid Stenting Candidates

Jason Kahn

September 28, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

News Daily News

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

September 11, 2012

Presentation

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Presenter: 89964|William Baker

September 10, 2012

News Daily News

Renal Denervation Reduces A-fib Recurrences in Small Study

Jason Kahn

September 07, 2012

News Daily News

La Denervación Renal Reduce las Recurrencias de la FA en un Pequeño Estudio

Jason Kahn

September 07, 2012

News Industry News

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

August 30, 2012

News Conference News ESC 2012

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Yael L. Maxwell

August 29, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

Advertisement

Novel Device Shows Promise for Safe, Effective LAA Closure

Percutaneous LAA Suture Ligation Using the LARIAT Device in Patients with A-fib

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib

JACC Viewpoint: Studies Needed on Long-term Consequences of ‘Silent’ Cerebral Infarcts

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Risk Score Predicts Stroke or Death in Carotid Stenting Candidates

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Dabigatran Usage up, Both for A-fib and Off-Label Indications

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Renal Denervation Reduces A-fib Recurrences in Small Study

La Denervación Renal Reduce las Recurrencias de la FA en un Pequeño Estudio

Landmark IMPROVE HF Trial Shows Evidence-Based Programs Result in Improvements in Heart Failure Patients Regardless of Race, and Improves Survival

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content